News

Memorial Sloan Kettering President Attends White House Signing

Memorial Sloan Kettering President Harold Varmus joined lawmakers, scientists, and patients on March 9 at a White House ceremony as President Barack Obama issued an executive order lifting the strict limits on human embryonic stem cell research.

Wednesday, July 1, 2009
Michael Overholtzer
An Interview with Michael Overholtzer

Michael Overholtzer is a recent recruit to Sloan Kettering Institute’s Cell Biology Program, he pairs this curiosity with a dedication to finding new ways to control disease.

Wednesday, July 1, 2009
Charles Sawyers (left) and Howard Scher
Advances in Development of New Targeted Therapy for Prostate Cancer Show Promise

A team of researchers led by Memorial Sloan Kettering physician-scientist Charles L. Sawyers has reported on the preclinical development and early results from the first clinical trial of a promising new drug for prostate cancer.

Wednesday, July 1, 2009
Dinshaw J. Patel
Dinshaw Patel Elected to the National Academy of Sciences

Dinshaw J. Patel, a Member in Sloan Kettering Institute’s Structural Biology Program and incumbent of the Abby Rockefeller Mauzé Chair in Experimental Therapeutics, was elected to the National Academy of Sciences at its 146th annual meeting in April.

Wednesday, July 1, 2009
Grégoire Altan-Bonnet
Two Young Investigators Named to New Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs

Memorial Sloan Kettering’s Boards of Overseers and Managers have announced the creation of the Bristol-Myers Squibb/James D. Robinson III Junior Faculty Chairs and have named the first two incumbents: Sloan Kettering Institute’s Grégoire Altan-Bonnet and Songhai Shi.

Wednesday, July 1, 2009
Jennifer A. Zallen
Jennifer Zallen Selected as Early Career Scientist By Howard Hughes Medical Institute

Jennifer A. Zallen, a member of the Developmental Biology Program in the Sloan Kettering Institute, has been selected by the Howard Hughes Medical Institute (HHMI) as an Early Career Scientist.

Wednesday, July 1, 2009
Memorial Sloan Kettering Investigator Named Dream Team Leader by Stand Up To Cancer

Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a “Dream Team” leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women’s cancers.

Wednesday, May 27, 2009
Picture: Joan Massagué
Genes Found to Play a Role in Breast Cancer's Spread to the Brain

New research led by investigators at Memorial Sloan Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.

Wednesday, May 6, 2009
The Geoffrey Beene Translational Oncology Core Facility

Using genetic tests to provide a prognosis and tailor treatment is becoming the standard of care for patients with a few forms of cancer.

Friday, May 1, 2009
David A. Scheinberg
David Scheinberg Elected to the Association of American Physicians

David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP).

Friday, May 1, 2009